Cited by 84Genomics and Phylogenetic StudiesGenomics and Rare DiseasesGenetics, Bioinformatics, and Biomedical Research

Next-Generation Sequencing: Advantages, Disadvantages, and Future

Ari, Şule, Arikan, Muzaffer·2016·Plant Omics: Trends and Applications

Integrity signals

Registry

Crossref · 10.1007/978-3-319-31703-8_5

Cites

85 of 85 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Currently, readout of the DNA sequences needed for data decoding relies heavily on established DNA sequencing technologies, most prominently sequencing-by-synthesis (SBS) as commercialized by Illumina.

    “Currently, readout of the DNA sequences needed for data decoding relies heavily on established technologies for DNA sequencing in life science applications, most prominently sequencing-by-synthesis (SBS) as commercialized by Illumina.”

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ari, Ş., & Arikan, M.
Venue
Plant Omics: Trends and Applications
Published
2016
Pages
109-135
OpenAlex
W2507429658
Cited by
84
References
85
Citations by year
2026: 7 · 2025: 13 · 2024: 16 · 2023: 8 · 2022: 7 · 2021: 3 · 2020: 13 · 2019: 6 · 2018: 8 · 2017: 3
FWCI
6.99
Type
book chapter
Language
en
Open access
closed
Locations
Springer eBooks (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Phylogenetic Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genetics, Bioinformatics, and Biomedical Research
Keywords
next-generation sequencing, DNA sequencing technologies, Sanger sequencing, long-read sequencing, sequencing platforms, sequencing cost reduction, sequencing bias, single-molecule sequencing, omics technologies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review